Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
Structure Therapeutics (NASDAQ: GPCR), a clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for metabolic and cardiopulmonary diseases, has announced its participation in the Jefferies London Healthcare Conference. The event will take place from November 19-21, 2024, in London, UK.
The company's management will deliver a presentation and participate in a fireside chat on Wednesday, November 20 at 8:00 a.m. GMT, while also hosting one-on-one meetings. A live webcast will be available on the company's website, with a replay accessible for 90 days following the event.
Structure Therapeutics (NASDAQ: GPCR), un'azienda biofarmaceutica in fase clinica focalizzata sullo sviluppo di terapie a piccole molecole orali per malattie metaboliche e cardiopolmonari, ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference. L'evento si svolgerà dal 19 al 21 novembre 2024 a Londra, Regno Unito.
Il management dell'azienda farà una presentazione e parteciperà a una chiacchierata informale mercoledì 20 novembre alle 8:00 GMT, ospitando anche incontri individuali. Una trasmissione in diretta sarà disponibile sul sito web dell'azienda, con la possibilità di avere una registrazione accessibile per 90 giorni dopo l'evento.
Structure Therapeutics (NASDAQ: GPCR), una compañía biofarmacéutica en etapa clínica centrada en el desarrollo de terapias orales con pequeñas moléculas para enfermedades metabólicas y cardiopulmonares, ha anunciado su participación en la Jefferies London Healthcare Conference. El evento se llevará a cabo del 19 al 21 de noviembre de 2024 en Londres, Reino Unido.
La dirección de la empresa realizará una presentación y participará en una charla en formato fireside el miércoles 20 de noviembre a las 8:00 a.m. GMT, mientras también se llevarán a cabo reuniones individuales. Se ofrecerá una transmisión en vivo en el sitio web de la empresa, con una repetición disponible durante 90 días después del evento.
Structure Therapeutics (NASDAQ: GPCR), 대사 및 심폐 질환을 위한 경구용 소분자 치료제를 개발하는 임상 단계의 생명공학 회사가 Jefferies London Healthcare Conference에 참가한다고 발표했습니다. 이 행사는 2024년 11월 19일부터 21일까지 영국 런던에서 열립니다.
회사의 경영진은 11월 20일 수요일 GMT 오전 8:00에 발표를 하고, 편안한 분위기의 대화에 참여하며, 개인별 회의도 진행합니다. 회사 웹사이트에서 생중계가 제공되며, 행사 후 90일 동안 재생이 가능합니다.
Structure Therapeutics (NASDAQ: GPCR), une entreprise biopharmaceutique en phase clinique axée sur le développement de thérapies orales à petite molécule pour les maladies métaboliques et cardiopulmonaires, a annoncé sa participation à la Jefferies London Healthcare Conference. L'événement se déroulera du 19 au 21 novembre 2024 à Londres, Royaume-Uni.
La direction de l'entreprise effectuera une présentation et participera à une discussion informelle le mercredi 20 novembre à 8h00 GMT, tout en animant également des réunions individuelles. Une diffusion en direct sera disponible sur le site web de l'entreprise, avec une rediffusion accessible pendant 90 jours après l'événement.
Structure Therapeutics (NASDAQ: GPCR), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung von oralen kleinen Molekültherapeutika für metabolische und herz- lungenerkrankungen konzentriert, hat seine Teilnahme an der Jefferies London Healthcare Conference angekündigt. Die Veranstaltung findet vom 19. bis 21. November 2024 in London, Großbritannien, statt.
Das Management des Unternehmens wird am Mittwoch, den 20. November, um 8:00 Uhr GMT eine Präsentation halten und an einer lockeren Gesprächsrunde teilnehmen sowie Einzelgespräche führen. Eine Live-Übertragung wird auf der Unternehmenswebsite verfügbar sein, und eine Aufzeichnung kann 90 Tage nach der Veranstaltung abgerufen werden.
- None.
- None.
SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that management will participate in a presentation and fireside chat, and host one-on-one meetings at the Jefferies London Healthcare Conference being held November 19-21, 2024, in London, UK.
Jefferies London Healthcare Conference
| Format: | Presentation and fireside chat | |
| Date/time: | Wednesday, November 20 at 8:00 a.m. GMT | |
The live and archived webcast will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and a replay will be available for 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.
Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
FAQ
When is Structure Therapeutics (GPCR) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch Structure Therapeutics' (GPCR) presentation at the Jefferies Conference?
What type of meetings will Structure Therapeutics (GPCR) host at the Jefferies London Healthcare Conference?
What is the duration of the Jefferies London Healthcare Conference where Structure Therapeutics (GPCR) is participating?
